How will rapidly developing technologies such as low cost genomic sequencing, artificial intelligence, telemedicine, robotics, 24/7 body wearable monitors, smart pills, stem cells, synthetic biology, gene therapy, mobile phone apps and crowd sourced health data affect the future of healthcare and medicine?
The FutureMed Program educates, informs and prepares physicians, innovators, inventors, investors and senior healthcare executives to understand and recognize the opportunities and disruptive influences of exponentially growing technologies within medicine and healthcare, and to understand how many rapidly developing and converging fields affect the future of clinical practice and the biomedical industry.
The program brings together leading thinkers and practitioners who will describe what is in the lab today and what is coming to market in the next 2 to 10 years. FutureMed focuses on breakthrough development ranging from 3D printing to organ regeneration, from point-of-care lab-on-a-chip diagnostics to large-scale bioinformatics; from synthetic biology to new gene based therapies. All of these and more are discussed in the context of the current explosions of digital information and distributed healthcare.